Pramipexole Pilot Phase II Study in Children and Adolescents With Tourette Disorder According to DSM-IV Criteria

NCT00558467 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Tourette Syndrome

Interventions

DRUG: pramipexole immediate release (IR)
DRUG: Placebo

Sponsor

Boehringer Ingelheim